Answers are grounded in this paper and cite their sources.
Retrospective cohort evaluated adalimumab's effect on inflammatory markers in hidradenitis suppurativa, revealing significant improvement.
Hidradenitis suppurativa (HS) is a recurrent chronic inflammatory disease marked by painful lesions in intertriginous regions. Recent studies highlight neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and C-reactive protein (CRP) as systemic inflammation markers correlated with disease severity. This study aimed to analyse changes in inflammatory parameters in HS patients pre- and post-16-week adalimumab treatment. We sought to understand if changes in these parameters have any correlation with response to treatment. A retrospective cohort of 44 adalimumab-treated HS patients was used to evaluate laboratory (NLR, PLR, MLR, CRP) and clinical (DLQI, IHS4, IHS4-55 and PI-NRS) parameters. Data, collected between 2019 and 2023, underwent statistical analysis including t-tests, Wilcoxon signed-rank tests and Pearson correlation tests, comparing pre- and post-treatment values. Adalimumab treatment led to a significant improvement in HS inflammatory markers. Clinical scores, including DLQI, (p<0.0001), IHS4 (p<0.0001) and PI-NRS (p<0.0001), showed significant reduction post-treatment. Analytical variables, NLR (p=0.02), PLR (p=0.02), CRP median (p=0.01), and MLR median (p=0.027), also exhibited significant decreases. In most patients, IHS4-55 scores did not show a 55% reduction. No significant correlation was found between baseline clinical scores and inflammatory parameters. All systemic inflammation-based biomarkers were significantly reduced after starting adalimumab. The clinical scores of DLQI, IHS4 and PI-NRS were also significantly decreased. Contrarily, in most patients, the IHS4-55 score did not show a 55% reduction. This suggests that haematological markers of inflammation may predict response to treatment with adalimumab.
No takes yet. Share an insight, caveat, or question.
Arce et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: